Effect of the Look AHEAD Study Intervention on Medication Use and Related Cost to Treat Cardiovascular Disease Risk Factors in Individuals With Type 2 Diabetes
Authors:
- J. Bruce RedmonJRJ. Bruce Redmon
- Alain G. BertoniABAlain G. Bertoni
- Stephen P. GlasserSGStephen P. Glasser
- the Look AHEAD Research GroupTGthe Look AHEAD Research Group
Open Access
- 23 March 2010
- journal article
- research article
- Published by American Diabetes Association in Diabetes Care
- Vol. 33 (6) , 1153-1158
Abstract
OBJECTIVE: To examine the effect of a lifestyle intervention to produce weight loss and increased physical fitness on use and cost of medications to treat cardiovascular disease (CVD) risk factors in people with type 2 diabetes. RESEARCH DESIGN AND METHODS: Look AHEAD is a multicenter randomized controlled trial of 5,145 overweight or obese individuals with type 2 diabetes, aged 45–76 years. An intensive lifestyle intervention (ILI) involving group and individual meetings to achieve and maintain weight loss through decreased caloric intake and increased physical activity was compared with a diabetes support and education (DSE) condition. Medications prescribed to treat diabetes, hypertension, and hyperlipidemia were compared at baseline and 1 year. Medication costs were conservatively estimated using prices from a national online pharmacy. RESULTS: Participants randomized to an ILI had significantly greater improvements in CVD risk parameters and reduced medication use and cost compared with those assigned to DSE. At 1 year, average number of medications prescribed to treat CVD risk factors was 3.1 ± 1.8 for the ILI group and 3.6 ± 1.8 for the DSE group (P < 0.0001), with estimated total monthly medication costs of $143 and $173, respectively (P < 0.0001). DSE participants meeting optimal care goals at 1 year were taking an average of 3.8 ± 1.6 medications at an estimated cost of $194/month. ILI participants at optimal care required fewer medications (3.2 ± 1.7) at lower cost ($154/month) (P < 0.001). CONCLUSIONS: At 1 year, ILI significantly improved CVD risk factors, while at the same time reduced medication use and cost. Continued intervention and follow-up will determine whether these changes are maintained and reduce cardiovascular risk.Keywords
This publication has 24 references indexed in Scilit:
- Forecasting the Effects of Obesity and Smoking on U.S. Life ExpectancyNew England Journal of Medicine, 2009
- Effects of Intensive Glucose Lowering in Type 2 DiabetesNew England Journal of Medicine, 2008
- Economic Costs of Diabetes in the U.S. in 2007Diabetes Care, 2008
- Standards of Medical Care in Diabetes—2008Diabetes Care, 2008
- Reduction in Weight and Cardiovascular Disease Risk Factors in Individuals With Type 2 DiabetesDiabetes Care, 2007
- Primary Prevention of Cardiovascular Diseases in People With Diabetes MellitusDiabetes Care, 2007
- Baseline characteristics of the randomised cohort from the Look AHEAD (Action for Health in Diabetes) studyDiabetes & Vascular Disease Research, 2006
- It Can Be DoneDiabetes Care, 2003
- Executive SummaryObesity Research, 1998
- Medication Cost Savings Associated with Weight-Loss for Obese Non-Insulin-Dependent Diabetic Men and WomenPreventive Medicine, 1995